LONDON, January 29, 2026--(BUSINESS WIRE)--Automata, the lab automation company building fully integrated, AI-ready platforms for life sciences, today announced the close of a $45 million Series C ...
In particular, 2B and 9S will have alternate versions of their cards. These designs will show them without their visors, allowing you to see their eyes. As for the cast signatures, you’ll be able to ...
New funding accelerates platform development and meets surging demand as pharma and biotech reimagine drug discovery Automata, the lab automation company building fully integrated, AI-ready platforms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results